Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Beam Therapeutics logo

Beam Therapeutics

Recent Finacing

Series B

Recent Raise

$135M

Beam Therapeutics develops precision DNA and RNA base-editing technologies that modify single nucleotides without cutting strands and advances therapeutic programs toward clinical development with delivery and targeting tools.

Founded 2017
Massachusetts, United States
251-500
Publicly Traded
beamtx.com

Highlights

Focus Areas

Biotechnology
Genetics
Medical
Therapeutics

Recent Investors

ARCH Venture Partners logo
F-Prime Capital logo
Eight Roads Ventures logo
Cormorant Asset Management logo
Google Ventures logo
Redmile Group logo
Altitude Life Science Ventures logo
Omega Funds logo

Financials

$222M

Total Raised

2

Funding rounds

8

Investors


Team

Upgrade to view the team

See the team members at Beam Therapeutics.